Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Anti-PD-1 bij progressieve multifocale leukencefalopathie?
jun 2019 | Multipele Sclerose